[EN] ANTAGONIST OF ADENOSINE RECEPTORS [FR] ANTAGONISTE DES RÉCEPTEURS DE L'ADÉNOSINE
摘要:
The present invention relates to compounds of formula I shown below: wherein R1, R4, R5and R6are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a and/or A2b receptor activity is implicated, such as, for example, cancer.
[EN] ANTAGONIST OF ADENOSINE RECEPTORS [FR] ANTAGONISTE DES RÉCEPTEURS DE L'ADÉNOSINE
摘要:
The present invention relates to compounds of formula I shown below: wherein R1, R4, R5and R6are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a and/or A2b receptor activity is implicated, such as, for example, cancer.
Aqueous syntheses of methylimidazo[1,2-a]pyridines without any deliberate addition of catalyst are reported. Imidazo[1,2-a]pyrazine and imidazo[2,1-a]isoquinoline were also obtained in good yields under similar conditions. With acetonitrile as solvent, Ag-catalyzed intra-molecular aminooxygenation produced imidazo[1,2-a]pyridine-3-carbaldehydes in moderate to good yields.